Micron Stock Is Up Over 1,000% Since 2025 and Is Now a $1 Trillion Company. Is It Still a Buy?

Micron is benefiting from a memory chip shortage driven by AI and data center expansion, with DRAM and NAND both in short supply. The article says the stock has rerated from under 5x forward earnings to 16x this fiscal year, but still trades at about 9x FY2027 earnings with analysts expecting 60% revenue growth in FY2027. The tone is constructive on Micron’s future returns, though the piece mainly offers valuation commentary rather than a new company catalyst.

Analysis

Micron’s setup is less about a one-time AI pop and more about a multi-year re-rating of the memory cycle’s duration and trough economics. The market is implicitly paying for scarcity persistence through FY27, but the bigger second-order effect is that sustained DRAM tightness can force hyperscalers to redesign bill-of-materials around memory efficiency, raising switching costs for everyone in the stack. That tends to benefit the highest-quality suppliers first, while eventually pressuring weaker competitors to chase capacity at the wrong point in the cycle.

The key risk is not demand collapse; it is supply response. Memory is one of the few AI-adjacent markets where capacity can still come back faster than investors expect once pricing signals remain elevated for multiple quarters, and the first sign will be incremental capex discipline breaking at peers rather than at Micron. If that happens, the forward multiple can compress quickly even if earnings are still rising, because the market will start discounting the next downcycle before it arrives.

The contrarian read is that consensus may be underestimating how much of MU’s upside is already being pulled forward by the AI narrative. A stock that rerates from deep-cycle multiples to mid-cycle multiples can still work, but the asymmetry shifts: future gains are now more dependent on continued estimate revisions than on multiple expansion. That makes earnings quality, wafer starts, and management capex commentary more important than headline revenue growth over the next 2-4 quarters.

Relative to the rest of semis, MU looks like the cleaner way to express memory scarcity, while NVDA remains the better quality AI beta and INTC is still a weak read-through. The best trade is to own the scarcity winner while avoiding names where the market may be over-discounting an eventual AI manufacturing spillover that has not yet converted into earnings power.

Key Decisions for Investors

• Long MU on pullbacks over the next 2-6 weeks; target a 6-9 month hold. Risk/reward is attractive if FY27 estimates keep moving up, but trim aggressively if the stock starts pricing in capex normalization before peers do.
• Pair trade: long MU / short INTC for the next 3-9 months. The spread should widen if memory tightness persists and capital allocation discipline differentiates winners from laggards.
• Use NVDA as the higher-quality AI exposure and MU as the more cyclical reflation leg; if already long semis, rotate a portion from NVDA into MU only on weakness, not strength, to improve expected upside capture.
• Buy MU upside via call spreads 6-12 months out instead of outright common if volatility remains elevated. This limits downside if memory prices peak earlier than expected while preserving re-rating upside.
• Reduce MU exposure if management commentary signals aggressive capacity additions across the industry; that would be the earliest indicator that the current supply deficit is transitioning into a 2027 oversupply setup.